For non-HER2 expression–related features, we discovered that the density of TILs in the tumor center (sTIL density) provides a significant stratification with cut points optimized on the full cohort (p=0.00055) as well as during cross-validation runs (see Supplementary Figs. S1 and S2). Here, ERBB2 is linked to neoplasm.